Literature DB >> 7960501

Yersinia enterocolitica: an inducer of chronic inflammation.

A Saebø1, J Lassen.   

Abstract

The aim of the present study was to elucidate the connection between yersiniosis and chronic inflammation. During the period 1974-83, Yersinia enterocolitica infection was diagnosed in 458 hospitalized patients by antibody response, or isolation. The patients were followed for 4-14 years (1987); 160 were readmitted with chronic disease. Fifty-three patients had persistent joint complaints, 18 developed ankylosing spondylitis, 14 rheumatoid arthritis, and 17 iridocyclitis. Thirty-eight patients suffered from chronic abdominal pain, and another 28 from chronic diarrhoea. Two who underwent proctocolectomy microscopically had ulcerative colitis. Eleven patients developed neurological disease; others developed conditions such as chronic nephritis, thyroid disease, insulin-dependent diabetes, etc. Chronic hepatitis, found in 22 patients, was significantly correlated with positive test for antinuclear antibody and rheumatoid factor, and with death. Several patients developed chronic multiorgan disease, probably with chronic hepatitis as pivot. Regarding the whole material, the difference between observed and expected cumulative survival rates remained significant for 8 years (0.9189 < 0.9456; p < 0.025), indicating a substantial impact on long-term survival exerted by chronic yersiniosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7960501

Source DB:  PubMed          Journal:  Int J Tissue React        ISSN: 0250-0868


  4 in total

1.  Novel diagnostic ELISA test for discrimination between infections with Yersinia enterocolitica and Yersinia pseudotuberculosis.

Authors:  Tomasz Wielkoszynski; Aliyeh Moghaddam; Assar Bäckman; Jessica Broden; Rafał Piotrowski; Renata Mond-Paszek; Alexander Kozarenko; Tor Ny; Malgorzata Wilczynska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-20       Impact factor: 3.267

Review 2.  Rheumatoid arthritis associated with ulcerative colitis.

Authors:  Y Adachi; Y Hinoda; H Takahashi; N Nakagawa; H Sakamoto; F Itoh; T Endo; S Suzuki; K Imai
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

3.  The landscape of host transcriptional response programs commonly perturbed by bacterial pathogens: towards host-oriented broad-spectrum drug targets.

Authors:  Yared H Kidane; Christopher Lawrence; T M Murali
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

4.  Chronic Lyme Disease and Co-infections: Differential Diagnosis.

Authors:  Walter Berghoff
Journal:  Open Neurol J       Date:  2012-12-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.